Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorIntervention: Biological: recombinant interleukin-12Sponsors: Indiana University; Indiana University School of Medicine; National Cancer Institute (NCI)Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials